The role of nuclear medicine in the evaluation of pancreatic disease

Surgical Clinics of North America

Volumn 81, Issue 2, 2001, Pages 345-358

  Van Heertum, Ronald L ^b   Fawwaz, Rashid A ^b  

^a Milstein Hospital   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; FLUORODEOXYGLUCOSE F 18; INDIUM 111; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC IMAGING; HUMAN; PANCREAS DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034996778     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70122-5     Document Type: Article

References (41)

1. S. Adams R. Baum T. Rink Limited value of fluorine-18-fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumors Eur J Nucl Med 25 1998 79 83
2. W.H. Bakker E.P. Krenning W.A.P. Breeman In vivo use of a radioiodinated somatostatin analogue: Dynamics, metabolism, and binding to somatostatin receptor positive tumors in man J Nucl Med 32 1991 1184 1189
3. W.H. Bakker E.P. Krenning J.C. Reubi In vivo application of 111-In-DTPA-D-Phe-Octreotide for the detection of somatostatin receptor positive tumors in rats Life Sci 49 1991 1593 1601
4. W. Bauer U. Brinner W. Dopfner A very potent and selective octapeptide analog of somatostatin with prolonged action Life Sci 31 1982 1133 1140
5. L. Buscail N. Saint-Laurent E. Chastre Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer Cancer Res 56 1996 1823 1827
6. U. Dorr K. Wurm E. Horing Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogues Horm Metab Res 27 Suppl 1993 36 44
7. D. Delbeke D.M. Rose W.C. Chapman Optimal interpretation of FDG PET in the diagnosis staging and management of pancreatic carcinoma J Nucl Med 40 1999 1784 1791
8. B. Erickson K. Oberg An update of the medical treatment of malignant endocrine tumors Acta Oncol 32 1993 203 208
9. J.S. Flier M.M. Mueckler P. Usher Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes Science 235 1987 1492 1495
10. A. Frilling M. Malago H. Martin Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors Surgery 124 1998 1000 1004
11. A. Frolich C.G. Diederichs L. Staib Detection of liver metastases from pancreatic cancer using FDG PET J Nucl Med 40 1996 250 255
12. P. Gold S.O. Freedman Specific carcinoembryonic antigens of the human digestive system J Exp Med 122 1965 467 481
13. F. Gibril J.C. Reynolds J.L. Doppman Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging agents in detecting primary and metastatic gastrinomas Ann Intern Med 125 1996 26 34
14. Y. Hiraki O.M. Rosen M.J. Birnbaum Growth factors rapidly induce expression of the transporter gene J Biol Chem 263 1988 13655 13662
15. T. Inokuma N. Tamaki T. Torizuka Evaluation of pancreatic tumors with positron emission tomography and F-18 flurodeoxyglucose: Comparison with CT and US Radiology 195 1995 345 352
16. M. John W. Meyerhof D. Richter Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2 Gut 38 1996 33 39
17. E.P. Krenning D.J. Kwekkeboom W.H. Bakker Somatostatin receptor scintigraphy with 111-In-DTPA-D-Phe- and 123-I-Tyr-octreotide: The Rotterdam experience with more than 1000 patients Eur J Nucl Med 20 1993 716 731
18. R. Kubota S. Yameda K. Kubota Intratumoral distribution of fluorine-18-flurodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 1992 1972 1980
19. A. Kubota Y. Yamada T. Torizuka Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in the treatment of human endocrine tumors J Clin Invest 93 1994 1321 1325
20. K. Kutz E. Nuesch J. Rosenthaler Pharmacokinetics of SMS 201-995 in healthy subjects Scand J Gastroenterol 21 suppl 119 1986 66 72
21. R.L. Lebtahi G. Cadiot L. Sarda Clinical impact of somatostatin scintigraphy in the management of patients with neuroendocrine gastroenterohepatic tumors J Nucl Med 38 1997 853 858
22. R.L. Lebtahi G. Cadiot N. Delahaye Detection of bone metastases in patients with endocrine gastroenterohepatic tumors compared with somatostatin receptor scintigraphy J Nucl Med 40 1999 1602 1608
23. I.M. Modlin E. Cornelius G.P. Lawton Use of isotopic somatostatin receptor probe to image gut endocrine tumors Arch Surg 130 1995 367 374
24. N.K. Monakhov E.L. Neistad M.M. Shavclkovskid Physiochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues J Natl Cancer Inst 61 1978 27 34
25. Y. Nakamoto T. Higashi H. Sakahara Evaluation of pancreatic islet cell tumors by 18-Fluorodeoxyglucose Positron Emission Tomography: Comparison with other modalities Clin Nucl Med 25 2000 115 119
26. B. Nakata Y.S. Chung S. Nishimura 18-Fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma Cancer 79 1996 695 699
27. A.G.E. Pearse The APUD cell concept and its implications in pathology Sommers S.C. Pathology Annual 1974 1974 Appleton-Century Crofts New York 27 41
28. D.A. Persons N. Schenk B.L. Hall Increased expression of glycolysis-associated genes in oncogene-transformed and growth accelerated states Mol Carcinog 2 1989 88 94
29. S. Reichlus Somatostatin N Engl J Med 309 1983 1495 1501
30. J.C. Reubi Neuropeptide receptors in health and disease: The molecular basis for in vivo imaging J Nucl Med 36 1995 1825 1835
31. J.C. Reubi J. Laissue B. Waser Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues Ann N Y Acad Sci 733 1994 122 127
32. M.D. Rose D. Debase D. Beauchamp 18-Flurodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer Ann Surg 229 1998 729 738
33. H. Cherub M. Bader U. Feet Somatostain receptor imaging of neuroendocrine gastroenterohepatic tumors Gastroenterology 195 1993 1705 1709
34. S.P. Sreedharan K.T. Kodammer K.E. Peterson Distinct subsets of somatostatin receptors on cultured human lymphocytes J Biol Chem 264 1989 949 953
35. J.C. Stollfuss G. Glatting H. Friess 2-(Florine-18)-fluoro-2-deoxy-D-glucose PET in the detection of pancreatic cancer: Value of quantitative image interpretation Radiology 195 1995 339 344
36. A. Thor N. Ohuchi C.A. Szpak Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3 Cancer Res 46 1986 3118 3124
37. O. Warburg On the origin of cancer cells Science 123 1956 309 314
38. S.R. Wise J. Johnston J. Sparks Gastrinoma: The predictive value of preoperative localization Surgery 106 1989 1097
39. E.A. Wottering R.O. Barrie T.M. Dorisio Detection of occult gastrinomas with Iodine-125 labeled lanreotide and intraoperative gamma detection Surgery 116 1994 1139 1147
40. G.A. Wiseman L.K. Kvols Therapy of neuroendocrine tumors with radiolabeled MIBG and somatostatin analogues Semin Nucl Med 25 1995 272 278
41. M. Zimmy R. Bares J. Fass Fluorine-18-fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases Eur J Nucl Med 24 1997 678 682